IRADIMED CORP — Director's Dealing 2020

Dec 10, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IRADIMED CORP (IRMD)
CIK: 0001325618
Period of Report: 2020-12-07

Reporting Person: Scott Christopher K. (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-12-07	Common Stock	M	1575	—	Acquired	24840	Direct
2019-12-07	Common Stock	F	384	$24.54	Disposed	24456	Direct
2020-12-07	Common Stock	M	2731	—	Acquired	27187	Direct
2019-12-07	Common Stock	F	665	$24.54	Disposed	26522	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-12-07	Restricted Stock Units	$	A	5094	Acquired		Common Stock (5094)	Direct
2020-12-07	Performance-Based Restricted Stock Units	$	A	5093	Acquired		Common Stock (5093)	Direct
2020-12-07	Restricted Stock Units	$	M	1575	Disposed		Common Stock (1575)	Direct
2020-12-07	Restricted Stock Units	$	M	2731	Disposed		Common Stock (2731)	Direct

Footnotes

F1: Restricted stock units convert into common stock on a one-for-one basis.

F2: Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock.

F3: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in full on the third anniversary of the grant date, December 7, 2023. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

F4: The reporting person received performance-based restricted stock units ("PRSUs") under Iradimed Corporation's 2014 Equity Incentive Plan. Vesting of these PRSUs depends on the reporting person's achievement of a specified relative ranking of total stockholder return over a three-year period from December 8, 2020 through December 7, 2023. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of PRSUs that have vested.

F5: On December 7, 2018, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

F6: On December 7, 2019, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2020. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.